RP Management, LLC
Follow13F filer, CIK 1507673, New York, NY
RP Management, LLC reported $148,723,022 across 3 holdings for the quarter ended 2023-12-31, in a 13F-HR filed 2024-02-13.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001507673-24-000002
- Period
- 2023-12-31
- Reported value
- $149M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Holdings, Q4 2023
Share positions as resolved from 13F-HR 0001507673-24-000002, largest first. % of portfolio is the value over $148,723,022, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| BHVNBIOHAVEN LTD | 2,936,507 | $126M | 84.51% | 0 | Timeline | ||
| BCRXBIOCRYST PHARMACEUTICALS INC | 3,846,154 | $23M | 15.49% | 0 | Timeline | ||
| VIRACTA THERAPEUTICS INCVIRACTA THERAPEUTICS INC | 3,700 | $2.11K | <0.01% | 0 |
How Q4 2023 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001507673-24-000002 | base | 2024-02-13 | acceptance time not in the bulk data set |